Stanton Mehr

Director of Content at Biosimilars Review & Report

The principal behind Biosimilar Review & Report, Stanton Mehr, is a veteran consultant, observer, and writer in the health care industry. Stan has decades of experience publishing on the pharmaceutical, managed care, and health policy areas. He has been reporting and consulting on the biosimilar industry since 2013, first as the founding content developer for the Center for Biosimilars, and then as Content Director for BR&R.

He has presented on several biosimilar topics; helped organize a biosimilar summit among payer representatives, academics, consultants, and employer representatives. He is also on the Editorial Advisory Board of the Journal of Managed Care and Specialty Pharmacy.

Stan Mehr has more than 30 years of experience in health care publishing and project management, specializing in the payer markets, clinical issues, health policy, and health delivery. He spent 20 years as Executive Vice President and Editorial Director of Medicom International Inc, where he was the Founding Editor of Managed Care Interface, the first monthly, peer-reviewed journal for the managed care industry, and its sister publication Long-Term Care Interface.